|1.||Yokota, Hiroki: 6 articles (04/2015 - 09/2012)|
|2.||Hamamura, Kazunori: 4 articles (04/2015 - 09/2012)|
|3.||Chen, Andy: 3 articles (04/2015 - 09/2012)|
|4.||Zhang, Ping: 3 articles (12/2013 - 09/2012)|
|5.||Liu, Chun-Lei: 2 articles (07/2015 - 09/2012)|
|6.||Li, Rui-Jun: 2 articles (07/2015 - 09/2012)|
|7.||He, Yun-Yun: 2 articles (07/2015 - 09/2012)|
|8.||Wang, Li-Li: 2 articles (07/2015 - 09/2012)|
|9.||He, Kun-Lun: 2 articles (07/2015 - 09/2012)|
|10.||Li, Xin: 2 articles (07/2015 - 09/2012)|
01/01/2010 - "Moreover, our data suggest the therapeutic efficacy of salubrinal in restraining NFκB mediated inflammation in the adult or older subjects."
04/01/2015 - "In this study, we examined the effects of salubrinal on expression of inflammation linked genes as well as a family of DUSP genes using genome-wide microarrays, qPCR, and RNA interference. "
12/05/2013 - "Furthermore, the inhibitory effect of tunicamycin on LPS-induced inflammation was not influenced by salubrinal, an ER stress inhibitor, suggesting that the anti-inflammatory effect of tunicamycin is independent of ER stress. "
04/01/2015 - "Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis."
07/01/2014 - "Cultured cardiomyocytes were pretreated with SP600125 or salubrinal, followed by tunicamycin to clarify the involvement of the IRE1α and PERK pathways in ERS inflammation. "
09/01/2012 - "Our study suggests that salubrinal protects rat cardiomyocytes against TM- or hypoxia-associated apoptosis via a mechanism involving the inhibition of ER stress-mediated apoptosis."
09/01/2012 - "HCS, TUNEL assays and flow cytometry showed that salubrinal protected cardiomyocytes against apoptosis induced by TM or hypoxia. "
09/01/2012 - "Cells were exposed to different concentrations of salubrinal (10, 20, and 40 µmol/L) for 30 min followed by TM treatment or hypoxia for 36 h. "
09/01/2012 - "This study examined the protective effect of salubrinal and the mechanism underlying this protection against tunicamycin (TM)- and hypoxia-induced apoptosis in rat cardiomyocytes. "
07/01/2014 - "A selective inhibitor of eukaryotic initiation factor-2a dephosphorylation, salubrinal, prevented C/EBP-homologous protein activation in the hippocampus and prefrontal cortex throughout hypoxia/reoxygenation exposure. "
01/01/2014 - "The administration of salubrinal significantly attenuated body weight loss and improved colitis, as assessed histologically. "
01/01/2014 - "We studied whether an inhibitor of the dephosphorylation of eukaryotic initiation factor 2α, salubrinal, improves murine experimental colitis through the amelioration of ER stress. "
01/01/2014 - "In IL10/Nox1dKO mice, salubrinal preserved eIF2α phosphorylation through inhibition of the regulatory subunit of the protein phosphatase 1 PP1R15A/GADD34 and prevented colitis. "
|5.||Memory Disorders (Memory Loss)
|2.||Guanabenz (BR 750)
|4.||Peptide Initiation Factors (Initiation Factor)
|5.||Small Interfering RNA (siRNA)
|6.||Eukaryotic Initiation Factor-2 (EIF 2)
|8.||Protein Phosphatase 1
|10.||Transcription Factor CHOP
|1.||Heterologous Transplantation (Xenotransplantation)